Burke Therapeutics, LLC Signs Exclusive US Marketing and Supply Agreement with Coeptis Pharmaceuticals, Inc. for Consensi®
March 11, 2020HOT SPRINGS, Ark.–(BUSINESS WIRE)–Burke Therapeutics, LLC, a commercial stage pharmaceutical company, today announced it has signed an exclusive marketing and supply agreement with Coeptis Pharmaceuticals, Inc. for the U.S. market. Burke will market the fixed-dose combination drug, Consensi®, a prescription medicine for adults who need both treatment with amlodipine for hypertension, to lower blood pressure, and celecoxib for the management of the signs and symptoms of osteoarthritis. Commercial launch is anticipated in May of 2020.
About Consensi
Consensi is a fixed-dose combination of amlodipine besylate, a calcium channel blocker for the treatment of hypertension, to lower blood pressure, and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID) for the management of the signs and symptoms of osteoarthritis. The U.S. Food & Drug Administration (FDA) approved Consensi oral tablets for marketing on May 31, 2018. For additional information see DailyMed, Full Prescribing Information, including BOXED WARNING and Medication Guide.
Indications and Usage
Consensi is indicated for adult patients for whom treatment with both amlodipine for hypertension and celecoxib for osteoarthritis are appropriate. Amlodipine is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal CV events, primarily strokes and myocardial infarctions. Celecoxib is indicated for the management of the signs and symptoms of osteoarthritis. Limitations of Use: Consensi is inappropriate for short-term or intermittent treatment or to treat any conditions other than hypertension in patients taking celecoxib for osteoarthritis. Consensi is only available in a celecoxib strength of 200 mg and is only to be taken once daily.
About Burke Therapeutics
Burke Therapeutics is a privately held commercial stage pharmaceutical company headquartered in Hot Springs, AR. The Company develops, acquires and commercializes a variety of specialty products to advance its development pipeline.
About Coeptis Pharmaceuticals
Coeptis Pharmaceuticals, Inc. is a privately held biopharmaceutical company engaged in the acquisition, development and commercialization of branded pharmaceutical products. Headquartered near Pittsburgh, PA, Coeptis Pharmaceuticals holds an expansive portfolio of 505(b)(2) assets in various stages of development and commercialization.
Important Safety Information (ISI) for Consensi®
WARNING: RISK OF SERIOUS CARDIOVASCULAR and GASTROINTESTINAL EVENTS See full prescribing information for complete boxed warning. CONSENSI contains celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), and amlodipine, a calcium channel blocker (CCB). NSAIDs can cause serious side effects, including:
|
What is the most important information I should know about Consensi? Consensi contains celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), and amlodipine, a calcium channel blocker (CCB). NSAIDs can cause serious side effects, including: |
|
• Increased risk of a heart attack or stroke that can lead to death. This risk may happen early in treatment and may increase:
|
|
Do not take Consensi right before or after a heart surgery called a “coronary artery bypass graft” (CABG). Avoid taking Consensi after a recent heart attack, unless your healthcare provider tells you to. You may have an increased risk of another heart attack if you take NSAIDs after a recent heart attack. |
|
• Increased risk of bleeding, ulcers, and tears (perforation) of the esophagus (tube leading from the mouth to the stomach), stomach, and intestines:
|
|
The risk of getting an ulcer or bleeding increases with:
|
|
|
|
You should not take other medicines that contain NSAIDs or salicylates during treatment with Consensi because of increased risk of stomach problems. Taking other medicines that contain NSAIDs or salicylates during treatment with Consensi will not provide increased relief of symptoms of osteoarthritis. |
|
Consensi should only be used:
|
|
Who should not take Consensi? Do not take Consensi: |
|
|
|
Before taking Consensi, tell your healthcare provider about all your medical conditions, including if you:
|
|
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Consensi® and some other medicines can interact with each other and cause serious side effects. Do not start taking any new medicine without talking to your healthcare provider first. What are the possible side effects of Consensi? |
|
Consensi can cause serious side effects, including: |
|
|
|
See “What is the most important information I should know about Consensi?” for further detail regarding serious side effects. Your healthcare provider will monitor your blood pressure and do blood tests to check you for side effects during treatment with Consensi. Consensi may cause fertility problems in females that is reversible when treatment with Consensi is stopped. Talk to your healthcare provider if this is a concern for you. |
|
The most common side effects of Consensi include: | |
|
|
Get emergency help right away if you get any of the following symptoms: | |
|
|
Stop taking Consensi and call your healthcare provider right away if you get any of the following symptoms: |
|
|
|
These are not all the possible side effects of Consensi. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Burke Therapeutics, LLC at 1-866-275-1264. Please see Full Prescribing Information, including BOXED WARNING, and Medication Guide. |
Contacts
Tim Dugan
Chief Operating Officer
Burke Therapeutics, LLC
3633 Central Avenue, Ste. I
Hot Spring, AR 71913
Phone: 501-620-4449
Fax: 501-321-2886
Email: [email protected]